DOCSLIB.ORG

Synthesis of New Β-Lactam Analogs and Evaluation of Their Histone Deacetylase (HDAC) Activity

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Synthesis of New Β-Lactam Analogs and Evaluation of Their Histone Deacetylase (HDAC) Activity Synthesis of New β-Lactam Analogs and Evaluation of Their Histone Deacetylase (HDAC) Activity Seikwan Oha, Jae-Chul Jungb, and Mitchell A. Averyc a Department of Neuroscience and Medical Research Institute, School of Medicine, Ewha Womans University, Seoul 158-710, South Korea b Ewha Global Challenge, BK21 and Medical Research Institute, School of Medicine, Ewha Womans University, Seoul 158-710, South Korea c Department of Medicinal Chemistry, School of Pharmacy, National Center for Natural Products Research & Department of Chemistry, University of Mississippi, University, MS 38677-1848, USA Reprint requests to Dr. Jae-Chul Jung. Fax: +82-02-2650-5791. E-mail: [email protected] Z. Naturforsch. 2007, 62b, 1459 – 1464; received April 16, 2007 A simple synthesis of the β-lactams 11 – 13 and 16 – 17 as novel histone deacetylase (HDAC) inhibitors is described. The key synthetic strategies involved the O-alkylation of 6-APA and the cou- pling reactions of freshly prepared N-carbobenzyloxy-L-prolines 5 and 6 and 6-aminopenicillanates 8 – 10 and 15 in high yields. It was found that all compounds show potent growth inhibitory activity on human tumor cell lines, the most potent compound 16 exhibiting an IC50 =2.1µ M in vitro. Key words: β-Lactams, Histone Deacetylase, Coupling Reaction, Anticancer, Synthesis Introduction (HDAC) as well as its acetylase inhibitors [11]. The small lactam (β and γ) derivatives are privileged struc- Since the introduction of β-lactam antibiotics, β- tures for enzyme inhibition, mainly due to their ability lactam substrates have stimulated significant interest to trap serine or cysteine residues in the DNA binding due to their wide range of intriguing biological activ- domain. ities [1] such as antibiotic [2], antioxidant [3], antivi- In a continuation of our medicinal chemistry pro- ral [4], and anticancer [5] properties. The variety of gram connected with the synthesis of new β-lactam the pharmacological activities of these β-lactams and moieties and evaluation of their biological proper- their unique structural features, including azetidin-2- ties, we required Cbz-protected L-prolines 5 – 6 and one rings, generated a great deal of interest among 6-aminopenicillanates 8 – 10, 15 as important frag- synthetic chemists and biologists. Recently, β-lactam ments in order to generate novel histone acetylase in- substrates with significant biological activities such hibitors. We wish to report herein a simple synthesis as serine-dependent enzyme inhibitors [6], matrix- and the evaluation of the anticancer activity of the 6- metalloprotease inhibitors [7], cysteine protease in- acylaminopenicillanates 11 – 13 and 16 – 17, starting hibitors [8], and apoptosis inductors [9] were reported from 6-aminopenicillanic acid (6-APA, 1) via O-alk- in the literature. Furthermore, they have served as syn- ylation and coupling reactions. thons in the preparation of various heterocyclic com- Results and Discussion pounds and potent anticancer agents such as paclitaxel, epothilones, and their analogs [10]. Current research To generate the Cbz-protected L-prolines 5 and 6, priorities for the β-lactam moieties are focused on pro- which are well known as a pharmacophore for HDAc viding better antibacterial efficacy and on biochemi- inhibitors, the commercially available L-proline (1) cal features as enzyme inhibitors including apoptos- and trans-4-hydroxy-L-proline (2) were treated with is-inducing properties. In addition, efforts to develop chlorotrimethylsilane (Me3SiCl) in the presence of di- optimal β-lactams as anticancer agents are underway. isopropylethylamine (DIPEA) in dichloromethane to More recently, histone acetylation was reasonably ac- yield the silyl-protected L-prolines 3 and 4,whichwere cepted as a mechanism of chromatin remodeling. It used in the next step without purification. Intermedi- is highly governed by the antagonistic activity of his- ates 3 and 4 were subsequently treated with benzyloxy- tone acetyltransferases (HAT) and histone deacetylase carbonyl chloride (Cbz-Cl) to give the Cbz-protected 0932–0776 / 07 / 1100–1459 $ 06.00 © 2007 Verlag der Zeitschrift f¨ur Naturforschung, T¨ubingen · http://znaturforsch.com 1460 S. Oh – J.-C. Jung · Synthesis of New β-Lactam Analogs and Evaluation of Their HDAC Activity Scheme 1. Synthesis of Cbz-protected L-prolines 5 and 6. Scheme 2. (a) For 8: bromoacetonitrile, TEA, acetone, r. t. 24 h, 42 %; for 9: allyl bromide, TEA, acetone, r. t. 36 h, 55 %; for 10: benzyl bromide, TEA, 4-DMAP, acetone, r. t. 48 h, 65 %; (b) 6, HATU, DIPEA, CH Cl ,r.t.16h,(68%for11,75% ◦ 2 2 for 12,76%for13); (c) dimethyldioxirane, CH2Cl2,0 Ctor.t.1h;then,CH2N2,CH2Cl2,r.t.1h;(d)CH2N2,CH2Cl2,r.t. 1h,95%;(e)5 – 6, HOBt, EDCI, TEA, CH2Cl2, r. t. 3 h, (80 % for 16,82%for17). L-prolines 5 and 6 in 97 and 95 % two-step yields, re- mide, and benzyl chloromethyl ether under SN2- spectively (Scheme 1). type reaction conditions including K2CO3/DMF [13], The β-lactam moieties 11 – 13 were prepared from DBU/CH3CN [14], and NaH/THF [15], but these readily generated 6-aminopenicillanates 8 – 10 [12] reactions were all unsatisfactory, and for the most with N-carbobenzyloxy-L-proline (5)andN-carbo- part the starting material was recovered. Com- benzyloxy-L-4-hydroxyproline (6) via common con- pounds 8 – 10 were readily coupled with 6 in the densation reactions. 6-Aminopenicillanic acid (6- presence of 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3- APA, 7) was treated with several alkylating reagents tetramethyluronium hexafluorophosphate (HATU) and such as bromoacetonitrile, allyl bromide, and ben- DIPEA in dichloromethane to afford 11 – 13 in good zyl bromide to give esters 8 – 10. At this stage, yields (Scheme 2). we tried to generate the various esters using sev- In addition, 6-APA (7) was treated with freshly pre- eral alkylating reagents such as bromochlorometh- pared diazomethane [16] in dichloromethane to af- ane, chloromethyl methyl ether, 4-methoxybenzyl bro- ford ester 15, in high yield. On the other hand, in S.Oh–J.-C.Jung· Synthesis of New β-Lactam Analogs and Evaluation of Their HDAC Activity 1461 an effort to prepare the sulfoxide 14,6-APA(7)was Table 1. HDAC and growth inhibiting potency of novel β- smoothly treated with 3,3-dimethyldioxirane (DMDO) lactam moities 6 – 10. a b [17] in dichloromethane to generate a sulfoxide, which Compound IC50 enzyme (µ M) IC50 cells (µ M) was then readily treated with diazomethane [18]. Un- 11 44.0 68.4 12 40.0 32.7 fortunately, these reactions failed to afford sulfox- 13 12.8 4.0 ide 14, leaving only starting material and/or decom- 16 6.3 2.1 posed products. Compound 15 was condensed with 17 11.8 5.5 acids 5 (Z-Hyp) or 6 (Z-Hyp-OH) using ethyl(di- Sodium butyratec – 140 c methylaminopropyl)carbodiimide (EDCI) and 1-hydr- Trichostatin A – 0.0046 a HDAC enzyme assay; b the values are means of three experiments oxybenzotriazole (HOBt) to generate 16, 17 in high [20]; c materials for comparison. yields [13]. At this stage, coupling of 15 with 5, 6 was also accomplished by dicyclohexylcarbodiimide with ethyl acetate, and radioactivity was measured by (DCC)/CH2Cl2,HATU/CH2Cl2, and bis(2-oxo-3-oxa- a liquid scintillation counter. zolidinyl)phosphinic chloride (BOP-Cl) in CH2Cl2. The in vitro anticancer activity of β-lactam moieties Although the latter conditions were more convenient, 11 – 13 and 16, 17 were evaluated in human tumor cell the HOBt/EDCI method afforded a superior yield. lines, and the results are summarized in Table 1. It was found that all compounds showed potent growth in- In vitro inhibition of histone deacetylase hibitory activity on human tumor cell lines with the most potent compound 16 exhibiting IC50 =2.1µ M. A histone deacetylase fraction was prepared as de- In addition, the methoxy esters 16, 17 (Table 1, entries scribed by Yoshida et al. [19]. Human leukemia K562 4, 5) or benzyl ester 13 (Table 1, entry 3) exhibited (2.5 × 108) cells were disrupted in buffer-A [15 mM higher in vitro growth inhibitory activity when com- of potassium phosphate buffer (pH 7.5) containing pared to cyanomethyl or allyl esters 11, 12. In addition, 5 % glycerol and 0.2 mM EDTA (15 mL)]. The nu- the novel β-lactam moieties 11 – 13 and 16, 17 showed clei were collected by centrifugation (35000 g, 10 min) better HDAC activity than sodium butyrate. However, and resuspended with buffer-A (15 mL) containing 1 M all prepared sulfonamides exhibited less HDAC activ- (NH4)2SO4. After sonication, the supernatant was col- ity than trichostatin A. lected by centrifugation, and ammonium sulfate was In conclusion, a simple preparation of new histone added to make the final concentration 3.5 M. After stir- deacetylase (HDAC) inhibitors has been described. ◦ ring for 1 h at 0 C, the precipitate was collected by Compound 16 exhibited the most potent anticancer ac- centrifugation, dissolved with buffer-A (4 mL), and di- tivity among these analogs. We expect that simple syn- alyzed against buffer-A (2000 mL). The dialysate was theses of new β-lactam moieties and key fragments loaded onto a mono Q HR 5/5 column (Pharmacia) are useful for the modification of histone acetylase in- equilibrated with buffer-A, and eluted with a linear gra- hibitors. dientof0–1 M NaCl in buffer-A (30 mL). A single peak of histone deacetylase activity was eluted around Experimental Section ◦ 0.4 M NaCl, and the fraction was stored at −80 C until Reactions requiring anhydrous conditions were performed use. Inhibition of histone deacetylase was estimated as with the usual precautions for rigorous exclusion of air and described by Yoshida et al. with slight modifications. moisture. Tetrahydrofuran was distilled from sodium ben- 3H-labeled histone was prepared as reported, K562 zophenone ketyl prior to use.
Load more

Recommended publications
  • Interplay Between Epigenetics and Metabolism in Oncogenesis: Mechanisms and Therapeutic Approaches
    OPEN Oncogene (2017) 36, 3359–3374 www.nature.com/onc REVIEW Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches CC Wong1, Y Qian2,3 and J Yu1 Epigenetic and metabolic alterations in cancer cells are highly intertwined. Oncogene-driven metabolic rewiring modifies the epigenetic landscape via modulating the activities of DNA and histone modification enzymes at the metabolite level. Conversely, epigenetic mechanisms regulate the expression of metabolic genes, thereby altering the metabolome. Epigenetic-metabolomic interplay has a critical role in tumourigenesis by coordinately sustaining cell proliferation, metastasis and pluripotency. Understanding the link between epigenetics and metabolism could unravel novel molecular targets, whose intervention may lead to improvements in cancer treatment. In this review, we summarized the recent discoveries linking epigenetics and metabolism and their underlying roles in tumorigenesis; and highlighted the promising molecular targets, with an update on the development of small molecule or biologic inhibitors against these abnormalities in cancer. Oncogene (2017) 36, 3359–3374; doi:10.1038/onc.2016.485; published online 16 January 2017 INTRODUCTION metabolic genes have also been identified as driver genes It has been appreciated since the early days of cancer research mutated in some cancers, such as isocitrate dehydrogenase 1 16 17 that the metabolic profiles of tumor cells differ significantly from and 2 (IDH1/2) in gliomas and acute myeloid leukemia (AML), 18 normal cells. Cancer cells have high metabolic demands and they succinate dehydrogenase (SDH) in paragangliomas and fuma- utilize nutrients with an altered metabolic program to support rate hydratase (FH) in hereditary leiomyomatosis and renal cell 19 their high proliferative rates and adapt to the hostile tumor cancer (HLRCC).
    [Show full text]
  • The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc Oncogenesis
    The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc oncogenesis By Yuting Sun This thesis is submitted in fulfilment of the requirements for the degree of Doctor of Philosophy at the University of New South Wales Children’s Cancer Institute Australia for Medical Research School of Women’s and Children’s Health, Faculty of Medicine University of New South Wales Australia August 2014 PLEASE TYPE THE UNIVERSITY OF NEW SOUTH WALES Thesis/Dissertation Sheet Surname or Family name: Sun First name: Yuting Other name/s: Abbreviation for degree as given in the University calendar: PhD School : School of·Women's and Children's Health Faculty: Faculty of Medicine Title: The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc oncogenesis. Abstract 350 words maximum: (PLEASE TYPE) N-Myc Induces neuroblastoma by regulating the expression of target genes and proteins, and N-Myc protein is degraded by Fbxw7 and NEDD4 and stabilized by Aurora A. The class lla histone deacetylase HDAC5 suppresses gene transcription, and blocks myoblast and leukaemia cell differentiation. While histone H3 lysine 4 (H3K4) trimethylation at target gene promoters is a pre-requisite for Myc· induced transcriptional activation, WDRS, as a histone H3K4 methyltransferase presenter, is required for H3K4 methylation and transcriptional activation mediated by a histone H3K4 methyltransferase complex. Here, I investigated the roles of HDAC5 and WDR5 in N-Myc overexpressing neuroblastoma. I have found that N-Myc upregulates HDAC5 protein expression, and that HDAC5 represses NEDD4 gene expression, increases Aurora A gene expression and consequently upregulates N-Myc protein expression in neuroblastoma cells.
    [Show full text]
  • The Histone Deacetylase HDA15 Interacts with MAC3A and MAC3B to Regulate Intron
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.386672; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 The histone deacetylase HDA15 interacts with MAC3A and MAC3B to regulate intron 2 retention of ABA-responsive genes 3 4 Yi-Tsung Tu1#, Chia-Yang Chen1#, Yi-Sui Huang1, Ming-Ren Yen2, Jo-Wei Allison Hsieh2,3, 5 Pao-Yang Chen2,3*and Keqiang Wu1* 6 7 1Institute of Plant Biology, National Taiwan University, Taipei 10617, Taiwan 8 2 Institute of Plant and Microbial Biology, Academia Sinica, Taipei 11529, Taiwan 9 3 Genome and Systems Biology Degree Program, Academia Sinica and National Taiwan 10 University, Taipei, Taiwan 11 12 # These authors contributed equally to this work. 13 * Corresponding authors: Keqiang Wu ([email protected], +886-2-3366-4546) and Pao-Yang 14 Chen ([email protected], +886-2-2787-1140) 15 16 Short title: HDA15 and MAC3A/MAC3B coregulate intron retention 17 One sentence summary: HDA15 and MAC3A/MAC3B coregulate intron retention and reduce 18 the histone acetylation level of the genomic regions near ABA-responsive retained introns. 19 20 The author responsible for distribution of materials integral to the findings presented in this 21 article in accordance with the policy described in the Instructions for Authors (www.plantcell.org) 22 is: Keqiang Wu ([email protected]) 23 24 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.386672; this version posted November 17, 2020.
    [Show full text]
  • Distinct Contributions of DNA Methylation and Histone Acetylation to the Genomic Occupancy of Transcription Factors
    Downloaded from genome.cshlp.org on October 8, 2021 - Published by Cold Spring Harbor Laboratory Press Research Distinct contributions of DNA methylation and histone acetylation to the genomic occupancy of transcription factors Martin Cusack,1 Hamish W. King,2 Paolo Spingardi,1 Benedikt M. Kessler,3 Robert J. Klose,2 and Skirmantas Kriaucionis1 1Ludwig Institute for Cancer Research, University of Oxford, Oxford, OX3 7DQ, United Kingdom; 2Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, United Kingdom; 3Target Discovery Institute, University of Oxford, Oxford, OX3 7FZ, United Kingdom Epigenetic modifications on chromatin play important roles in regulating gene expression. Although chromatin states are often governed by multilayered structure, how individual pathways contribute to gene expression remains poorly under- stood. For example, DNA methylation is known to regulate transcription factor binding but also to recruit methyl-CpG binding proteins that affect chromatin structure through the activity of histone deacetylase complexes (HDACs). Both of these mechanisms can potentially affect gene expression, but the importance of each, and whether these activities are inte- grated to achieve appropriate gene regulation, remains largely unknown. To address this important question, we measured gene expression, chromatin accessibility, and transcription factor occupancy in wild-type or DNA methylation-deficient mouse embryonic stem cells following HDAC inhibition. We observe widespread increases in chromatin accessibility at ret- rotransposons when HDACs are inhibited, and this is magnified when cells also lack DNA methylation. A subset of these elements has elevated binding of the YY1 and GABPA transcription factors and increased expression. The pronounced ad- ditive effect of HDAC inhibition in DNA methylation–deficient cells demonstrates that DNA methylation and histone deacetylation act largely independently to suppress transcription factor binding and gene expression.
    [Show full text]
  • Pan-Histone Deacetylase Inhibitors Regulate Signaling Pathways
    Majumdar et al. BMC Genomics 2012, 13:709 http://www.biomedcentral.com/1471-2164/13/709 RESEARCH ARTICLE Open Access Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells Gipsy Majumdar1, Piyatilake Adris1, Neha Bhargava1, Hao Chen2 and Rajendra Raghow1,2* Abstract Background: We have shown previously that pan-HDAC inhibitors (HDACIs) m-carboxycinnamic acid bis-hydroxamide (CBHA) and trichostatin A (TSA) attenuated cardiac hypertrophy in BALB/c mice by inducing hyper-acetylation of cardiac chromatin that was accompanied by suppression of pro-inflammatory gene networks. However, it was not feasible to determine the precise contribution of the myocytes- and non-myocytes to HDACI-induced gene expression in the intact heart. Therefore, the current study was undertaken with a primary goal of elucidating temporal changes in the transcriptomes of cardiac myocytes exposed to CBHA and TSA. Results: We incubated H9c2 cardiac myocytes in growth medium containing either of the two HDACIs for 6h and 24h and analyzed changes in gene expression using Illumina microarrays. H9c2 cells exposed to TSA for 6h and 24h led to differential expression of 468 and 231 genes, respectively. In contrast, cardiac myocytes incubated with CBHA for 6h and 24h elicited differential expression of 768 and 999 genes, respectively. We analyzed CBHA- and TSA-induced differentially expressed genes by Ingenuity Pathway (IPA), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Core_TF programs and discovered that CBHA and TSA impinged on several common gene networks. Thus, both HDACIs induced a repertoire of signaling kinases (PTEN-PI3K-AKT and MAPK) and transcription factors (Myc, p53, NFkB and HNF4A) representing canonical TGFβ, TNF-α, IFNγ and IL-6 specific networks.
    [Show full text]
  • Histone Deacetylase Inhibitors Synergizes with Catalytic Inhibitors of EZH2 to Exhibit Anti-Tumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
    Author Manuscript Published OnlineFirst on September 19, 2018; DOI: 10.1158/1535-7163.MCT-18-0348 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Histone deacetylase inhibitors synergizes with catalytic inhibitors of EZH2 to exhibit anti- tumor activity in small cell carcinoma of the ovary, hypercalcemic type Yemin Wang1,2,*, Shary Yuting Chen1,2, Shane Colborne3, Galen Lambert2, Chae Young Shin2, Nancy Dos Santos4, Krystal A. Orlando5, Jessica D. Lang6, William P.D. Hendricks6, Marcel B. Bally4, Anthony N. Karnezis1,2, Ralf Hass7, T. Michael Underhill8, Gregg B. Morin3,9, Jeffrey M. Trent6, Bernard E. Weissman5, David G. Huntsman1,2,10,* 1Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada 2Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada. 3Michael Smith Genome Science Centre, British Columbia Cancer Agency, Vancouver, BC, Canada. 4Department of Experimental Therapeutics, British Columbia Cancer Research Centre, Vancouver, BC, Canada. 5Department of Pathology and Laboratory Medicine and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. 6Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA. 7Department of Obstetrics and Gynecology, Hannover Medical School, D-30625 Hannover, Germany. 8Department of Cellular and Physiological Sciences and Biomedical Research Centre, University 1 Downloaded from mct.aacrjournals.org on September 26, 2021. © 2018 American Association for Cancer Research. Author Manuscript Published OnlineFirst on September 19, 2018; DOI: 10.1158/1535-7163.MCT-18-0348 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • Phosphate Availability and Ectomycorrhizal Symbiosis with Pinus Sylvestris Have Independent Effects on the Paxillus Involutus Transcriptome
    This is a repository copy of Phosphate availability and ectomycorrhizal symbiosis with Pinus sylvestris have independent effects on the Paxillus involutus transcriptome. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/168854/ Version: Published Version Article: Paparokidou, C., Leake, J.R. orcid.org/0000-0001-8364-7616, Beerling, D.J. et al. (1 more author) (2020) Phosphate availability and ectomycorrhizal symbiosis with Pinus sylvestris have independent effects on the Paxillus involutus transcriptome. Mycorrhiza. ISSN 0940- 6360 https://doi.org/10.1007/s00572-020-01001-6 Reuse This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the authors for the original work. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Mycorrhiza https://doi.org/10.1007/s00572-020-01001-6 ORIGINAL ARTICLE Phosphate availability and ectomycorrhizal symbiosis with Pinus sylvestris have independent effects on the Paxillus involutus transcriptome Christina Paparokidou1 & Jonathan R. Leake1 & David J. Beerling1 & Stephen A. Rolfe1 Received: 16 June 2020 /Accepted: 29 October 2020 # The Author(s) 2020 Abstract Many plant species form symbioses with ectomycorrhizal fungi, which help them forage for limiting nutrients in the soil such as inorganic phosphate (Pi).
    [Show full text]
  • SET-Induced Calcium Signaling and MAPK/ERK Pathway Activation Mediate Dendritic Cell-Like Differentiation of U937 Cells
    Leukemia (2005) 19, 1439–1445 & 2005 Nature Publishing Group All rights reserved 0887-6924/05 $30.00 www.nature.com/leu SET-induced calcium signaling and MAPK/ERK pathway activation mediate dendritic cell-like differentiation of U937 cells A Kandilci1 and GC Grosveld1 1Department of Genetics and Tumor Cell Biology, Mail Stop 331, St Jude Children’s Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA Human SET, a target of chromosomal translocation in human G1/S transition by allowing cyclin E–CDK2 activity in the leukemia encodes a highly conserved, ubiquitously expressed, presence of p21.11 Second, SET interacts with cyclin B–CDK1.19 nuclear phosphoprotein. SET mediates many functions includ- ing chromatin remodeling, transcription, apoptosis and cell Overexpression of SET inhibits cyclin B-CDK1 activity, which in cycle control. We report that overexpression of SET directs turn, blocks the G2/M transition; this finding suggests a negative 13 differentiation of the human promonocytic cell line U937 along regulatory role for SET in G2/M transition. Overexpression of the dendritic cell (DC) pathway, as cells display typical cell division autoantigen-1 (CDA1), another member of the morphologic changes associated with DC fate and express NAP/SET family, inhibits proliferation and decreases bromo- the DC surface markers CD11b and CD86. Differentiation occurs deoxyuridine uptake in HeLa cells.20 Acidic and basic domains via a calcium-dependent mechanism involving the CaMKII and 20 MAPK/ERK pathways. Similar responses are elicited by inter- of CDA1 show 40% identity and 68% similarity to SET. feron-c (IFN-c) treatment with the distinction that IFN-c signaling We have recently shown that overexpression of SET in the activates the DNA-binding activity of STAT1 whereas SET human promonocytic cell line U937 causes G0/G1 arrest and overexpression does not.
    [Show full text]
  • Active Site Tyrosine Is Essential for Amidohydrolase but Not for Esterase
    Active site tyrosine is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme Kristin Moreth, Daniel Riester, Christian Hildmann, René Hempel, Dennis Wegener, Andreas Schober, Andreas Schwienhorst To cite this version: Kristin Moreth, Daniel Riester, Christian Hildmann, René Hempel, Dennis Wegener, et al.. Ac- tive site tyrosine is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme. Biochemical Journal, Portland Press, 2006, 401 (3), pp.659-665. 10.1042/BJ20061239. hal-00478649 HAL Id: hal-00478649 https://hal.archives-ouvertes.fr/hal-00478649 Submitted on 30 Apr 2010 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Biochemical Journal Immediate Publication. Published on 12 Oct 2006 as manuscript BJ20061239 Active site tyrosine is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme Kristin Moreth¶, Daniel Riester¶, Christian Hildmann¶, René Hempel¶, Dennis Wegener¶,§,‡,
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • Grimme, Acadia.Pdf
    MECHANISM OF ACTION OF HISTONE DEACETYLASE INHIBITORS ON SURVIVAL MOTOR NEURON 2 PROMOTER by Acadia L. Grimme A thesis submitted to the Faculty of the University of Delaware in partial fulfillment of the requirements for the degree of Bachelors of Science in Biological Sciences with Distinction Spring 2018 © 2018 Acadia Grimme All Rights Reserved MECHANISM OF ACTION OF HISTONE DEACETYLASE INHIBITORS ON SURVIVAL MOTOR NEURON 2 PROMOTER by Acadia L. Grimme Approved: __________________________________________________________ Matthew E. R. Butchbach, Ph.D. Professor in charge of thesis on behalf of the Advisory Committee Approved: __________________________________________________________ Deni S. Galileo, Ph.D. Professor in charge of thesis on behalf of the Advisory Committee Approved: __________________________________________________________ Carlton R. Cooper, Ph.D. Committee member from the Department of Biological Sciences Approved: __________________________________________________________ Gary H. Laverty, Ph.D. Committee member from the Board of Senior Thesis Readers Approved: __________________________________________________________ Michael Chajes, Ph.D. Chair of the University Committee on Student and Faculty Honors ACKNOWLEDGMENTS I would like to acknowledge my thesis director Dr. Butchbach for his wonderful guidance and patience as I worked through my project. He has been an excellent research mentor over the last two years and I am forever thankful that he welcomed me into his lab. His dedication to his work inspires me as an aspiring research scientist. His lessons will carry on with me as I pursue future research in graduate school and beyond. I would like to thank both current and former members of the Motor Neuron Disease Laboratory: Sambee Kanda, Kyle Hinkle, and Andrew Connell. Sambee and Andrew patiently taught me many of the techniques I utilized in my project, and without them it would not be what it is today.
    [Show full text]
  • Genome-Wide Investigation of Cellular Functions for Trna Nucleus
    Genome-wide Investigation of Cellular Functions for tRNA Nucleus- Cytoplasm Trafficking in the Yeast Saccharomyces cerevisiae DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Hui-Yi Chu Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2012 Dissertation Committee: Anita K. Hopper, Advisor Stephen Osmani Kurt Fredrick Jane Jackman Copyright by Hui-Yi Chu 2012 Abstract In eukaryotic cells tRNAs are transcribed in the nucleus and exported to the cytoplasm for their essential role in protein synthesis. This export event was thought to be unidirectional. Surprisingly, several lines of evidence showed that mature cytoplasmic tRNAs shuttle between nucleus and cytoplasm and their distribution is nutrient-dependent. This newly discovered tRNA retrograde process is conserved from yeast to vertebrates. Although how exactly the tRNA nuclear-cytoplasmic trafficking is regulated is still under investigation, previous studies identified several transporters involved in tRNA subcellular dynamics. At least three members of the β-importin family function in tRNA nuclear-cytoplasmic intracellular movement: (1) Los1 functions in both the tRNA primary export and re-export processes; (2) Mtr10, directly or indirectly, is responsible for the constitutive retrograde import of cytoplasmic tRNA to the nucleus; (3) Msn5 functions solely in the re-export process. In this thesis I focus on the physiological role(s) of the tRNA nuclear retrograde pathway. One possibility is that nuclear accumulation of cytoplasmic tRNA serves to modulate translation of particular transcripts. To test this hypothesis, I compared expression profiles from non-translating mRNAs and polyribosome-bound translating mRNAs collected from msn5Δ and mtr10Δ mutants and wild-type cells, in fed or acute amino acid starvation conditions.
    [Show full text]